AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Jala-ML Tablet

Prescription Icon
Prescription Required

Marketer

Ajala Pharmaceuticals

Salt Composition

Levocetirizine (5mg) + Montelukast (10mg)

Overview Jala-ML Tablet

Aller-Comb tablets combine medications to alleviate allergic reactions. These reactions include nasal congestion, runny nose, sneezing, itching, swelling, watery eyes, and airway inflammation. The tablets ease breathing difficulties. Dosage and treatment length are determined by your physician and depend on your response to the medication. Complete the prescribed course; premature cessation may cause symptom recurrence and worsen your condition. Inform your doctor of all other medications you're using, as interactions are possible. Common side effects, such as nausea, diarrhea, vomiting, dry mouth, headache, rash, flu-like symptoms, and fatigue, are usually temporary. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or tasks requiring alertness until the effects are known. Alcohol should be avoided due to increased drowsiness. Never self-medicate or share your prescription. Adequate hydration is recommended. Disclose any kidney disease to your doctor before starting treatment.

Uses of Jala-ML Tablet

Managing allergic skin reactions | Alleviating allergic rhinitis symptoms (sneezing and rhinorrhea) | Treating seasonal allergic conjunctivitis and rhinitis

Major Benefits of Jala-ML Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Jala-ML Tablets can be consumed with or without food; however, consistent timing is recommended for optimal results.

Common Side effects of Jala-ML Tablet:

  • Nausea
  • Diarrhea
  • Dryness in mouth
  • Fatigue
  • Headache
  • Skin rash
  • Sleepiness
  • Vomiting
  • Upper respiratory tract infection
  • Sore throat
  • Fever
  • Abdominal pain
  • Increased liver enzymes

How to use Jala-ML Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Jala-ML Tablets can be consumed with or without food, though consistent timing is recommended.

How Jala-ML Tablet works:

Aller-Comb tablets contain levocetirizine and montelukast, effectively alleviating allergic symptoms like sneezing and nasal discharge. Levocetirizine, an antihistamine, counteracts histamine, a substance triggering nasal congestion, watery eyes, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits the action of leukotrienes, inflammatory mediators. This dual action reduces airway and nasal inflammation, providing symptomatic relief.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use of alcohol while taking Jala-ML Tablets requires careful consideration. Seek medical advice before combining them.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Jala-ML Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harmful effects on fetal development; nonetheless, data from human trials are scarce.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Jala-ML Tablets. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking Jala-ML Tablets may cause drowsiness, blurred vision, dizziness, and reduced awareness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Jala-ML Tablets, potentially requiring dosage modification under medical supervision. Jala-ML Tablets are contraindicated in individuals with severely compromised kidney function.

LiverLiverCAUTION

Exercise caution when administering Jala-ML Tablets to individuals with advanced hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Jala-ML Tablet use in such patients is limited. Dosage alteration is not advised for those with mild or moderate liver dysfunction.

What if you forget to take Jala-ML Tablet :

Should you forget a Jala-ML Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Jala-ML Tablet

LabelValue
Developing Habits No.
Type of Therapy Breathing

FAQs on Jala-ML Tablet

Jala-ML Tablet combines Montelukast and Levocetirizine to alleviate allergy symptoms. Levocetirizine, an antihistamine, reduces allergy-causing chemicals, relieving runny nose, sneezing, watery eyes, and cough. Montelukast blocks leukotrienes, reducing airway and nasal inflammation for further symptom relief.
Jala-ML Tablets commonly cause drowsiness. Avoid driving, operating machinery, or other activities requiring alertness unless your doctor advises otherwise. Refrain from alcohol and other central nervous system depressants (including cough/cold remedies, pain relievers, and sleep aids) to prevent excessive drowsiness and the risk of falls or accidents.
Continue taking Jala-ML tablets as prescribed. If you develop side effects or your allergies worsen, contact your doctor for assessment.
Dry mouth is a possible side effect of Jala-ML Tablet. To counteract this, drink plenty of water throughout the day, including keeping some by your bedside. Use lip balm if needed.
Avoid alcohol while taking Jala-ML tablets; alcohol will worsen the medication's drowsiness.
Increasing your Jala-ML Tablet dosage won't improve its effectiveness; it only increases the risk of side effects. For worsening symptoms, seek medical advice.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Jala-ML Tablet
167